microdose glp 1 for inflammation Can GLP-1 Agonists Help Autoimmune Disease? Beyond Weight Loss: How GLP-1

It is confusing that there have not been more human trials, with some phase 1 oral trials in Mexico never being completed (unclear if adverse events or lack of efficacy)

Emphasis is placed on clinical screening, controlled titration, and ongoing monitoring to align outcomes with safety parameters

Glucagon-like peptide-1 (GLP-1) receptor agonists, originally developed for type-2 diabetes, have become the wealthy and elites darlings of weight management, as they mimic a gut hormone to curb appetite and regulate blood sugar

However, more research needs to be done

Discontinue use if any adverse reactions occur and consult a healthcare professional